Table 1 Aim 1 outcomes
Outcomes | Specific indicators | Study Aim |
|---|---|---|
Engagement in antenatal care (ANC) | Number of women living with HIV (WLWH) entering antenatal care (ANC) each year since 2004 | Aim 1 |
Trends in age of WHWH first accessing HIV care during ANC | Aim 1 | |
Number of subsequent pregnancies per WLWH | Aim 1 | |
Initiation of antiretroviral therapy (ART) | Proportion of WLWH receiving pre-ART blood tests during ANC | Aim 1 |
HIV viremia | Proportion of WLWH with major (> 1000 copies/mL) and minor (50–1000 copies/mL) viremia during ANC | Aim 1 |
Proportion of women with major (> 1000 copies/mL) and minor (50–1000 copies/mL) viremia within first 2 years postpartum | Aim 1 | |
Association between viremic episodes and timing of ART initiation | Aim 1 | |
Continuity of HIV care | Proportion of WLWH continuously in care (≤12 months between visits) over study period | Aim 1 |
Proportion of WLWH only seen at ANC and then lost after first pregnancy (> 12 months since last visit) | Aim 1 | |
Proportion of WLWH who only engage in HIV care during pregnancy episodes (first and subsequent) | Aim 1 | |
Proportion of WLWH who re-engage in care after LTFU (> 12 months) | Aim 1 | |
Geographic distribution of continuity of care | Aim 1 |